89 related articles for article (PubMed ID: 24951497)
1. Intestinal and renal handling of oxalate loads in normal individuals and stone formers.
Knight J; Holmes RP; Assimos DG
Urol Res; 2007 Jun; 35(3):111-7. PubMed ID: 17431604
[TBL] [Abstract][Full Text] [Related]
2. Activation of the PKA signaling pathway stimulates oxalate transport by human intestinal Caco2-BBE cells.
Arvans D; Alshaikh A; Bashir M; Weber C; Hassan H
Am J Physiol Cell Physiol; 2020 Feb; 318(2):C372-C379. PubMed ID: 31825656
[TBL] [Abstract][Full Text] [Related]
3. Corin Deficiency Diminishes Intestinal Sodium Excretion in Mice.
Gu X; Wang K; Li W; He M; Zhou T; Liu M; Wu Q; Dong N
Biology (Basel); 2023 Jul; 12(7):. PubMed ID: 37508377
[TBL] [Abstract][Full Text] [Related]
4. The effects of drinking bicarbonate-rich mineral water in calcium oxalate stone formers: an open label prospective randomized controlled study in an Asian cohort.
Lu Y; Sundaram P; Li H; Chong TW
Int Urol Nephrol; 2022 Sep; 54(9):2133-2140. PubMed ID: 35781772
[TBL] [Abstract][Full Text] [Related]
5. The role of NHE3 (Slc9a3) in oxalate and sodium transport by mouse intestine and regulation by cAMP.
Stephens CE; Whittamore JM; Hatch M
Physiol Rep; 2021 Apr; 9(7):e14828. PubMed ID: 33904662
[TBL] [Abstract][Full Text] [Related]
6. Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluria.
D'Costa MR; Kausz AT; Carroll KJ; Ingimarsson JP; Enders FT; Mara KC; Mehta RA; Lieske JC
Nephrol Dial Transplant; 2021 Dec; 36(12):2208-2215. PubMed ID: 33367720
[TBL] [Abstract][Full Text] [Related]
7. Animal models of naturally occurring stone disease.
Alford A; Furrow E; Borofsky M; Lulich J
Nat Rev Urol; 2020 Dec; 17(12):691-705. PubMed ID: 33159170
[TBL] [Abstract][Full Text] [Related]
8. miR-125a-5p: a novel regulator of SLC26A6 expression in intestinal epithelial cells.
Anbazhagan AN; Priyamvada S; Borthakur A; Saksena S; Gill RK; Alrefai WA; Dudeja PK
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C200-C208. PubMed ID: 31042422
[TBL] [Abstract][Full Text] [Related]
9. Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia.
Whittamore JM; Stephens CE; Hatch M
Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G82-G94. PubMed ID: 30383413
[TBL] [Abstract][Full Text] [Related]
10. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.
Milliner D; Hoppe B; Groothoff J
Urolithiasis; 2018 Aug; 46(4):313-323. PubMed ID: 28718073
[TBL] [Abstract][Full Text] [Related]
11. Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?
Peck AB; Canales BK; Nguyen CQ
Urolithiasis; 2016 Feb; 44(1):45-50. PubMed ID: 26645869
[TBL] [Abstract][Full Text] [Related]
12. Lowering urinary oxalate excretion to decrease calcium oxalate stone disease.
Holmes RP; Knight J; Assimos DG
Urolithiasis; 2016 Feb; 44(1):27-32. PubMed ID: 26614109
[TBL] [Abstract][Full Text] [Related]
13. Intestinal adaptations in chronic kidney disease and the influence of gastric bypass surgery.
Hatch M
Exp Physiol; 2014 Sep; 99(9):1163-7. PubMed ID: 24951497
[TBL] [Abstract][Full Text] [Related]
14. Sel1-like proteins and peptides are the major
Arvans D; Chang C; Alshaikh A; Tesar C; Babnigg G; Wolfgeher D; Kron S; Antonopoulos D; Bashir M; Cham C; Musch M; Chang E; Joachimiak A; Hassan H
Am J Physiol Cell Physiol; 2023 Jul; 325(1):C344-C361. PubMed ID: 37125773
[TBL] [Abstract][Full Text] [Related]
15. [Hyperoxaluria and renal calculi].
Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
[TBL] [Abstract][Full Text] [Related]
16. Enhanced gastrointestinal passive paracellular permeability contributes to the obesity-associated hyperoxaluria.
Bashir M; Meddings J; Alshaikh A; Jung D; Le K; Amin R; Ratakonda S; Sharma S; Granja I; Satti M; Asplin J; Hassan H
Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G1-G14. PubMed ID: 30307745
[TBL] [Abstract][Full Text] [Related]
17. The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man.
Whittamore JM; Hatch M
Urolithiasis; 2017 Feb; 45(1):89-108. PubMed ID: 27913853
[TBL] [Abstract][Full Text] [Related]
18. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
Lindsjö M
Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
